Literature DB >> 18252210

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.

Gaofeng Wang1, Joelle M van der Walt, Gregory Mayhew, Yi-Ju Li, Stephan Züchner, William K Scott, Eden R Martin, Jeffery M Vance.   

Abstract

Parkinson disease (PD) is a common neurodegenerative disorder caused by environmental and genetic factors. We have previously shown linkage of PD to chromosome 8p. Subsequently, fibroblast growth factor 20 (FGF20) at 8p21.3-22 was identified as a risk factor in several association studies. To identify the risk-conferring polymorphism in FGF20, we performed genetic and functional analysis of single-nucleotide polymorphisms within the gene. In a sample of 729 nuclear families with 1089 affected and 1165 unaffected individuals, the strongest evidence of association came from rs12720208 in the 3' untranslated region of FGF20. We show in several functional assays that the risk allele for rs12720208 disrupts a binding site for microRNA-433, increasing translation of FGF20 in vitro and in vivo. In a cell-based system and in PD brains, this increase in translation of FGF20 is correlated with increased alpha-synuclein expression, which has previously been shown to cause PD through both overexpression and point mutations. We suggest a novel mechanism of action for PD risk in which the modulation of the susceptibility gene's translation by common variations interfere with the regulation mechanisms of microRNA. We propose this is likely to be a common mechanism of genetic modulation of individual susceptibility to complex disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18252210      PMCID: PMC2427225          DOI: 10.1016/j.ajhg.2007.09.021

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  33 in total

1.  Correcting for a potential bias in the pedigree disequilibrium test.

Authors:  E R Martin; M P Bass; N L Kaplan
Journal:  Am J Hum Genet       Date:  2001-04       Impact factor: 11.025

2.  GOLD--graphical overview of linkage disequilibrium.

Authors:  G R Abecasis; W O Cookson
Journal:  Bioinformatics       Date:  2000-02       Impact factor: 6.937

3.  Muscarinic receptor stimulation induces translocation of an alpha-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasm.

Authors:  Y Leng; T N Chase; M C Bennett
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

4.  Complete genomic screen in Parkinson disease: evidence for multiple genes.

Authors:  W K Scott; M A Nance; R L Watts; J P Hubble; W C Koller; K Lyons; R Pahwa; M B Stern; A Colcher; B C Hiner; J Jankovic; W G Ondo; F H Allen; C G Goetz; G W Small; D Masterman; F Mastaglia; N G Laing; J M Stajich; B Slotterbeck; M W Booze; R C Ribble; E Rampersaud; S G West; R A Gibson; L T Middleton; A D Roses; J L Haines; B L Scott; J M Vance; M A Pericak-Vance
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

5.  Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c.

Authors:  Shigeki Ohmachi; Tadahisa Mikami; Morichika Konishi; Ayumi Miyake; Nobuyuki Itoh
Journal:  J Neurosci Res       Date:  2003-05-15       Impact factor: 4.164

6.  Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture.

Authors:  Wenbo Zhou; Jerome Schaack; W Michael Zawada; Curt R Freed
Journal:  Brain Res       Date:  2002-02-01       Impact factor: 3.252

7.  Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.

Authors:  Deniz Kirik; Carl Rosenblad; Corinna Burger; Cecilia Lundberg; Teit E Johansen; Nicholas Muzyczka; Ronald J Mandel; Anders Björklund
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

8.  FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain.

Authors:  S Ohmachi; Y Watanabe; T Mikami; N Kusu; T Ibi; A Akaike; N Itoh
Journal:  Biochem Biophys Res Commun       Date:  2000-10-22       Impact factor: 3.575

9.  Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons.

Authors:  Hardy J Rideout; Paula Dietrich; Magali Savalle; William T Dauer; Leonidas Stefanis
Journal:  J Neurochem       Date:  2003-02       Impact factor: 5.372

Review 10.  Parkinson's disease: piecing together a genetic jigsaw.

Authors:  M C J Dekker; V Bonifati; C M van Duijn
Journal:  Brain       Date:  2003-05-21       Impact factor: 13.501

View more
  206 in total

1.  A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.

Authors:  Lucía F Cardo; Eliecer Coto; Lorena de Mena; René Ribacoba; Oswaldo Lorenzo-Betancor; Pau Pastor; Lluis Samaranch; Ignacio F Mata; Marta Díaz; Germán Moris; Manuel Menéndez; Ana I Corao; Victoria Alvarez
Journal:  J Mol Neurosci       Date:  2011-11-11       Impact factor: 3.444

2.  The AVPR1A gene and substance use disorders: association, replication, and functional evidence.

Authors:  Brion S Maher; Vladimir I Vladimirov; Shawn J Latendresse; Dawn L Thiselton; Rebecca McNamee; Moonsu Kang; Tim B Bigdeli; Xiangning Chen; Brien P Riley; John M Hettema; Howard Chilcoat; Christian Heidbreder; Pierandrea Muglia; E Lenn Murrelle; Danielle M Dick; Fazil Aliev; Arpana Agrawal; Howard J Edenberg; John Kramer; John Nurnberger; Jay A Tischfield; Bernie Devlin; Robert E Ferrell; Galina P Kirillova; Ralph E Tarter; Kenneth S Kendler; Michael M Vanyukov
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

Review 3.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

Review 4.  Functions of noncoding RNAs in neural development and neurological diseases.

Authors:  Shan Bian; Tao Sun
Journal:  Mol Neurobiol       Date:  2011-10-04       Impact factor: 5.590

Review 5.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

6.  Demonstrating polymorphic miRNA-mediated gene regulation in vivo: application to the g+6223G->A mutation of Texel sheep.

Authors:  Haruko Takeda; Carole Charlier; Frédéric Farnir; Michel Georges
Journal:  RNA       Date:  2010-08-02       Impact factor: 4.942

7.  MicroRNA polymorphisms: a giant leap towards personalized medicine.

Authors:  Prasun J Mishra
Journal:  Per Med       Date:  2009-03-01       Impact factor: 2.512

8.  Genetic variation in FGF20 modulates hippocampal biology.

Authors:  Herve Lemaitre; Venkata S Mattay; Fabio Sambataro; Beth Verchinski; Richard E Straub; Joseph H Callicott; Raja Kittappa; Thomas M Hyde; Barbara K Lipska; Joel E Kleinman; Ronald McKay; Daniel R Weinberger
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

9.  miRNA-9 expression is upregulated in the spinal cord of G93A-SOD1 transgenic mice.

Authors:  Fenghua Zhou; Yingjun Guan; Yanchun Chen; Caixia Zhang; Li Yu; Hailing Gao; Hongmei Du; Bing Liu; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

10.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.